beta-lapachone has been researched along with Invasiveness, Neoplasm in 2 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, Z | 1 |
Zhang, L | 1 |
Zhou, J | 1 |
Zhou, S | 1 |
Li, L | 1 |
Guo, X | 1 |
Feng, G | 1 |
Ma, Z | 1 |
Huang, W | 1 |
Huang, F | 1 |
Kim, SO | 1 |
Kwon, JI | 1 |
Jeong, YK | 1 |
Kim, GY | 1 |
Kim, ND | 1 |
Choi, YH | 1 |
2 other studies available for beta-lapachone and Invasiveness, Neoplasm
Article | Year |
---|---|
mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27.
Topics: Animals; Antineoplastic Agents; Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome; Brain Neoplasms; | 2017 |
Induction of Egr-1 is associated with anti-metastatic and anti-invasive ability of beta-lapachone in human hepatocarcinoma cells.
Topics: Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Early Growth Response Protein | 2007 |